Kardigan, Inc. (KARD)

NASDAQ

$14.44

$-1.99

(-12.07%)

Regular Market

Kardigan, Inc. (KARD) Live Price Chart

Last updated: ⁦2026-09-23 18:28:20⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Kardigan, Inc. (KARD) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $14.44, with a market capitalization of $1.52B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $14.40 to $27.00. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$1.52B
Open	$16.50
Day's High	$27.00
Day's Low	$14.40
Previous Close	$16.44
Volume	360.38K
Average Volume	470.89K
P/E Ratio	--
52-Week High	$27.00
52-Week Low	$14.40
Dividend Yield	--
Earnings Date	--

Kardigan, Inc. (KARD) Stock Price Today

Kardigan, Inc. (KARD) is currently trading at $14.44 as of 2026-09-23 18:12:19, down 12.20% ($2.01) from the previous close of $16.44

During today's regular trading session, KARD has traded between $14.40 and $27.00, with a trading volume of 360.38K shares. The current price is near the lower end of today's range.

Kardigan, Inc. (KARD) 7-Day Stock Price Change

Over the past seven days, Kardigan, Inc. (KARD) moved from $19.05 to $14.44, representing a decline of 24.23% ($4.62).

The stock traded between $14.40 and $19.39 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 1.53 million shares, up versus the previous seven-day period, indicating higher trading activity.

KARD 52-Week Price Position

Position in Range: 0.3%

52W Low$14.40

52W High$27.00

KARD is currently trading at $14.44, placing it 0.3% of the way from its 52-week low of $14.40 to its 52-week high of $27.00. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Kardigan, Inc. (KARD)?

Kardigan Inc is a clinical-stage therapeutics company focused on developing medicines for cardiovascular diseases. Its activities include the research and development of targeted therapies for cardiovascular conditions for which no approved treatments currently exist. The company's clinical-stage programs include Danicamtiv, Ataciguat, and Tonlamarsen, which are being developed for cardiovascular disease indications. The company operates and manages its business as a single operating and reportable segment, focused on the discovery and development of novel therapeutic products to treat cardiovascular disease.

Kardigan, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Exchange	NASDAQ
Company Website	https://www.kardigan.bio

How to Buy Kardigan, Inc. (KARD) Stock on MEXC

Eligible investors can buy real shares of Kardigan, Inc. (KARD) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for KARD and Place Your Order

Open the RealStocks trading page and search for KARD. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Kardigan, Inc. (KARD) stock price today?

Kardigan, Inc. (KARD) is currently trading at $ 14.44, down 12.20% ($2.01) from the previous close of $ 16.44. Intraday prices update in real time during regular trading hours.

2.Is KARD stock going up or down today?

As of 2026-09-23 18:12:19, KARD is trading at $ 14.44, down 12.20% ($2.01) from its previous close of $ 16.44. The stock has traded between $ 14.40 and $ 27.00 during today’s regular session. Past price movements do not guarantee future results.

3.What is KARD pre-market price?

As of 2026-09-23 18:12:19, KARD is trading at $ 16.36 in pre-market trading, down 0.51% ($0.08) from the previous close of $ 16.44. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is KARD after-hours price?

As of 2026-09-23 18:12:19, KARD is trading at $ 16.51 in after-hours trading, up 0.43% ($0.07) from the regular-session close of $ 16.44. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is KARD stock trading now?

KARD trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does KARD sit relative to its 52-week high and low?

Over the past 52 weeks, KARD has traded between a low of $ 14.40 and a high of $ 27.00. At $ 14.44, the stock is positioned 0.3% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Kardigan, Inc. in?

Kardigan, Inc. (KARD) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Kardigan, Inc.'s market capitalization and where is it listed?

Kardigan, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 1.52B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is KARD valued in terms of P/E ratio and EPS?

KARD trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Kardigan, Inc. pay a dividend?

Kardigan, Inc. pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.